HIV Vaccine Trials Network Opens Enrollment For Phase 1 Trial Of...
May 23, 2012 | Posted by: roboblogger | Full story: BioResearch Online
GeoVax Labs, Inc. , an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus infections, today announced that the NIH-funded HIV Vaccine Trials Network has opened enrollment for a Phase 1 trial for the company's second-generation HIV vaccine.
Since: Sep 10
How 'bout THAT...right on the heels of Obamas gay marriage statement!
70 Users are viewing the Health Forum right now
|NSU tobacco free effective Friday||17 min||Yep||45|
|Guest column: Anti-vaccination movement threate...||2 hr||friend||24|
|Misconceptions lead some to avoid vaccinations||2 hr||Vaccine Spectrum Disorder||1|
|Pregnancy Symptoms - 12 Very Early Symptoms of ... (Jun '07)||5 hr||Justmyluck||5,893|
|New mosquito-borne viral disease found in South...||5 hr||CDC so where will u go||1|
|Growing e-cigarette trend raises safety concerns (Jul '13)||5 hr||Ronald||113|
|CO2 Alzheimer's Link (Aug '12)||6 hr||Nobel Prize maybe||72|
|B-12 and Lipotropic Injections for Weight Loss (Jun '06)||Thu||Kristy||4,685|